WGRX
WELLGISTICS HLTH (WGRX)
NASDAQ
$4.10-$0.29 (-6.61%)
Price as of Jun 03, 2026 7:52 PM EDT
  • $8.6M
    Market Cap
  • -95.52%
    1-Year Change
  • Pharmaceutical Retailers
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
23.3M
+28.73%
18.1M
N/A
Cost of Revenue
29.8M
+81.92%
16.4M
N/A
Gross Profit
-6.4M
-463.63%
1.8M
N/A
Sales and Marketing Expense
1.2M
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
158,804
+134.86%
67,616
N/A
Total Operating Expenses
87.3M
+1,003.61%
7.9M
N/A
Operating Profit
-93.7M
+1,425.58%
-6.1M
N/A
Interest Income
42,045
-65.07%
120,373
N/A
Interest Expense
-1.4M
N/A
N/A
N/A
Interest Income and Expense and Net
-1.3M
-1,206.02%
120,373
N/A
Total Nonoperating Income and Expense
-7.5M
+958.29%
-711,094
N/A
Income before Taxes
-101.3M
+1,377.12%
-6.9M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
0
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
Net Income from Continuing Operations Applicable to Common
-101.3M
+1,377.12%
-6.9M
N/A
Basic EPS and Net Income
-1.43
+853.33%
-0.15
N/A
Diluted EPS and Net Income
-1.43
+853.33%
-0.15
N/A
Basic Weighted Average Shares
71.0M
+50.23%
47.3M
N/A
Diluted Weighted Average Shares
71.0M
+50.23%
47.3M
N/A
Balance Sheet
Cash and Cash Equivalents
42,571
-95.86%
1.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
42,571
-95.86%
1.0M
N/A
Total Current Assets
2.8M
-81.41%
15.2M
N/A
Accumulated Depreciation
1.3M
+14.18%
1.1M
N/A
Property and Plant and Equipment and Net
229,376
-40.91%
388,180
N/A
Total Long-Term Assets
229,376
-83.86%
1.4M
N/A
Total Assets
30.5M
-46.87%
57.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
10.9M
-8.72%
11.9M
N/A
Total Current Liabilities
29.8M
-21.73%
38.0M
N/A
Total Long-Term Debt
23.5M
+131.29%
10.2M
N/A
Total Long-Term Liabilities
527,122
-95.29%
11.2M
N/A
Total Liabilities
42.9M
-15.20%
50.6M
N/A
Retained Earnings
-111.0M
+1,037.95%
-9.8M
N/A
Total Stockholders Equity
-12.4M
-284.84%
6.7M
N/A
Total Shares Outstanding
101.3M
+98.43%
51.1M
N/A
Cash Flow
Cash from Operating Activities
-10.9M
+786.13%
-1.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-881,526
-287.93%
469,072
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.8M
+503.00%
1.8M
N/A
Financials Ratio
Gross Margin
-27.54%
N/A
N/A
N/A
Operating Margin
-401.70%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
28.73%
N/A
N/A
N/A
Current Ratio
0.09
N/A
N/A
N/A
Cash Ratio
0.001
N/A
N/A
N/A
Debt-to-Equity Ratio
-2.76
N/A
N/A
N/A
Debt-to-Assets Ratio
1.13
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow